Pharma giant Boehringer Ingelheim backs startup program Rock Health
The endorsement comes as San Francisco-based Rock Health announces a new class of 11 startups for its accelerator program, which provides access to guidance, financing and experts to help the young operations succeed.
Reactions
(10)
This is certainly a great trend to see Pharmas involved in these types onf early stage project. Why to understand how technology impacts their busienss.
As the key point
"For software companies targeting drugmakers, it's typically way more difficult to get customers than to create products. Pharma giants have been historically slow adopters of new IT, and that is a challenge that these accelerator programs could help new companies address."